Dr. Yang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7185 Liberty Centre Dr
Ste D
Liberty Township, OH 45069Phone+1 513-443-2506Fax+1 432-999-9256
Summary
- Dr. Michael Yang is a general ophthalmologist who specializes in pediatric ophthalmology and adult strabismus. He founded his own practice at Liberty Eye Center in Liberty Township, OH in the northern Cincinnati area. He was formerly the division director in pediatric ophthalmology at Cincinnati Children's Hospital Medical Center from 2014 to 2023. He received his medical degree from Harvard Medical School, his residency training at University of Southern California/Doheny Eye Institute, and his fellowship training at Kellogg Eye Center at University of Michigan. He has been in practice for 25 years. He specializes in pediatric ophthalmology & adult strabismus and is experienced in glaucoma and related disorders, complex strabismus repair, cataract, retinopathy of prematurity, and nystagmus.
Education & Training
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Ophthalmology, 1994 - 1997
- St Elizabeth's Medical CenterInternship, Internal Medicine, 1993 - 1994
- Harvard Medical SchoolClass of 1993
Certifications & Licensure
- CA State Medical License 1995 - 2025
- KY State Medical License 2004 - 2025
- OH State Medical License 2002 - 2025
- IN State Medical License 2021 - 2021
- MI State Medical License 1998 - 2002
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Honor Award American Academy of Ophthalmology, 2016
- Honor Award American Association for Pediatric Ophthalmology and Strabismus, 2016
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP Start of enrollment: 2022 Apr 27
Roles: Contact
- Bevacizumab Treatment For Type 1 ROP Start of enrollment: 2022 May 18
Roles: Contact
Publications & Presentations
PubMed
- 94 citationsAssessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing StudyDavid K. Wallace, Raymond T. Kraker, Sharon F. Freedman, Eric R. Crouch, Amy K. Hutchinson
JAMA Ophthalmology. 2017-06-01 - 18 citationsCataract development associated with long-term glucocorticoid therapy in Duchenne muscular dystrophy patients.Melissa L Rice, Brenda Wong, Paul S. Horn, Michael B. Yang
Journal of AAPOS. 2018-06-01 - 5 citationsOcular and developmental outcomes of a dosing study of bevacizumab for retinopathy of prematurity.David K Wallace, Amra Hercinovic, Sharon F Freedman, Eric R Crouch, Amit R Bhatt
Journal of AAPOS. 2023-02-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: